» Articles » PMID: 9499049

Identification of a Domain Within the Human T-cell Leukemia Virus Type 2 Envelope Required for Syncytium Induction and Replication

Overview
Journal J Virol
Date 1998 Mar 14
PMID 9499049
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro infection by human T-cell leukemia virus type 1 and 2 (HTLV-1 and HTLV-2) can result in syncytium formation, facilitating viral entry. Using cell lines that were susceptible to HTLV-2-mediated syncytium formation but were nonfusogenic with HTLV-1, we constructed chimeric envelopes between HTLV-1 and -2 and assayed for the ability to induce syncytia in BJAB cells and HeLa cells. We have identified a fusion domain composed of the first 64 amino acids at the amino terminus of the HTLV-2 transmembrane protein, p21, the retention of which was required for syncytium induction. Construction of replication-competent HTLV genomic clones allowed us to correlate the ability of HTLV-2 to induce syncytia with the ability to replicate in BJAB cells. Differences in the ability to induce syncytia were not due to differences in the levels of total or cell membrane-associated envelope or in the formation of multimers. Therefore, we have localized a fusion domain within the amino terminus of the transmembrane protein of HTLV-2 envelope that is necessary for syncytium induction and viral replication.

Citing Articles

Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope.

Lamb D, Schuttelkopf A, van Aalten D, Brighty D Retrovirology. 2008; 5:70.

PMID: 18680566 PMC: 2533354. DOI: 10.1186/1742-4690-5-70.


Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.

Xie L, Green P J Virol. 2005; 79(23):14536-45.

PMID: 16282453 PMC: 1287554. DOI: 10.1128/JVI.79.23.14536-14545.2005.


Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin.

Jassal S, Pohler R, Brighty D J Virol. 2001; 75(17):8317-28.

PMID: 11483777 PMC: 115076. DOI: 10.1128/jvi.75.17.8317-8328.2001.


Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.

Rosenberg A, Delamarre L, Preira A, Dokhelar M J Virol. 1998; 72(9):7609-14.

PMID: 9696862 PMC: 110017. DOI: 10.1128/JVI.72.9.7609-7614.1998.

References
1.
Chesebro B, Nishio J, Perryman S, Cann A, OBrien W, Chen I . Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J Virol. 1991; 65(11):5782-9. PMC: 250239. DOI: 10.1128/JVI.65.11.5782-5789.1991. View

2.
Page K, Stearns S, Littman D . Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity. J Virol. 1992; 66(1):524-33. PMC: 238313. DOI: 10.1128/JVI.66.1.524-533.1992. View

3.
Ivanoff L, Looney D, McDanal C, Morris J, Wong-Staal F, Langlois A . Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. AIDS Res Hum Retroviruses. 1991; 7(7):595-603. DOI: 10.1089/aid.1991.7.595. View

4.
Hall W, Takahashi H, Liu C, Kaplan M, Scheewind O, Ijichi S . Multiple isolates and characteristics of human T-cell leukemia virus type II. J Virol. 1992; 66(4):2456-63. PMC: 289041. DOI: 10.1128/JVI.66.4.2456-2463.1992. View

5.
Sharpless N, OBRIEN W, Verdin E, Kufta C, Chen I, Dubois-Dalcq M . Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism. J Virol. 1992; 66(4):2588-93. PMC: 289063. DOI: 10.1128/JVI.66.4.2588-2593.1992. View